Posts tagged with "Merck"

Biden to donate 500 million doses of Pfizer vaccine worldwide over a year

June 11, 2021

In a speech set to be delivered on Thursday, June 10, on the eve G7 Cornwall Summit in the United Kingdom, President Joe Biden plans to  outline plans for the United States to donate 500 million Pfizer-BioNTech vaccine doses to about 100 nations worldwide over the next year—in addition to the 80 million doses he already has pledged will be delivered by the end of this month.

According to a report by The New York Times, in making the announcement, the president will challenge his fellow G-7 leaders— from the United Kingdom, Canada, France, Germany, Italy, and Japan—to step up vaccine distribution in their own nations and in others in order to beat the COVID-19 pandemic.

The White House reached the deal just in time for Biden’s eight-day European trip, which offers his first opportunity to reassert the United States as a world leader and restore relations that were badly frayed by former President Donald Trump.

“We have to end COVID-19, not just at home, which we’re doing, but everywhere,” Biden told American troops after landing at R.A.F. Mildenhall in Suffolk, England, on June 9. “There’s no wall high enough to keep us safe from this pandemic or the next biological threat we face, and there will be others. It requires coordinated multilateral action.”

People familiar with the Pfizer deal said the United States would pay for the doses at a “not-for-profit” price. The first 200 million doses will be distributed by the end of this year, followed by 300 million by next June, they said. The doses will be distributed through COVAX, the international vaccine-sharing initiative.

Biden is in Europe for a week to attend the NATO and Group of 7 summits and to meet with President Vladimir Putin of Russia in Geneva. In a statement on Wednesday, Jeffrey Zients, the White House official in charge of devising a global vaccination strategy, said Biden would “rally the world’s democracies around solving this crisis globally, with America leading the way to create the arsenal of vaccines that will be critical in our global fight against Covid-19.”

According to the Times, the White House is trying to spotlight its success in fighting the pandemic — particularly its vaccination campaign — and use that success as a diplomatic tool, especially as China and Russia seek to do the same. Mr. Biden has been insistent that, unlike China and Russia, which have been sharing their vaccines with dozens of countries, the United States will not seek to extract promises from countries receiving American-made vaccines.

The 500 million doses still fall far short of the 11 billion the World Health Organization estimates are needed to vaccinate the world, but significantly exceed what the United States has committed to share so far. Other nations have been pleading with the United States to give up some of its abundant vaccine supplies. Less than 1% of people are fully vaccinated in a number of African countries, compared with 42% in the United States and the United Kingdom.

Advocates for global health welcomed the news, but reiterated their stance that it is not enough for the United States to simply give vaccine away. They say the Biden Administration must create the conditions for other countries to manufacture vaccines on their own, including transferring technology to make the doses.

“The world needs urgent new manufacturing to produce billions more doses within a year, not just commitments to buy the planned inadequate supply,” Peter Maybarduk, the director of Public Citizen’s Access to Medicines program, said in a statement. He added, “We have yet to see a plan from the U.S. government or the G7 of the needed ambition or urgency to make billions more doses and end the pandemic.”

The deal with Pfizer has the potential to open the door to similar agreements with other vaccine manufacturers, including Moderna, whose vaccine was developed with American tax dollars—unlike Pfizer’s. In addition, the Biden administration has brokered a deal in which Merck will help produce Johnson & Johnson’s vaccine, and those doses might be available for overseas use.

The United States has already contracted to buy 300 million doses of the Pfizer-BioNTech vaccine, which requires two shots, for distribution in the United States; the 500 million doses are in addition to that, according to people familiar with the deal.

Research contact: @nytimes

Hundreds of companies, CEOs band together to defend and protect voting access

April 15, 2021

Hundreds of business leaders and companies—including Amazon, JPMorgan Chase, General Motors,. and Netflix—have signed on to a statement promising to “defend the right to vote and oppose any discriminatory legislation” in the latest corporate response to a wave of Republican-led voting suppression bills being advanced in dozens of states.

Among the executive signatories are BlackRock CEO Larry Fink, Berkshire Hathaway CEO Warren Buffet, and Bloomberg CEO Michael Bloomberg.

According to a report by The Wall Street Journal, more than 300 companies, CEOs, and other executives signed the statement, which appeared as a full-page advertisement in The New York Times and other publications on March 14.

It was organized by Kenneth Chenault, the former chief executive of American Express, and Kenneth Frazier, CEO of Merck.

“There is overwhelming support in corporate America for this principle of voting rights,” Chenault said. “The right to vote is fundamental to America. It is not a partisan issue.”

According to the Journal, the statement doesn’t directly address specific voting legislation, nor does it call on companies to take business action or halt political donations to lawmakers supporting such bills.

“Clearly, we’re not being prescriptive about how people manifest their opposition,” Chenault said. “Who in their right mind would say that they want legislation that will limit people’s ability to vote?”

Research contact: @WSJ

WebMD announces acquisition of Aptus Health

October 1, 2019

New York City-based WebMD, an online leader in health information services, announced on September 30, that it had entered into an agreement to acquire Reading, Massachusetts-based Aptus Health.

The acquisition includes Aptus Health’s core brand Univadis, a global information and education platform delivering medical news, conference and research updates and thought-leader education to 4 million healthcare practitioners in 91 countries.

In addition, the transaction includes Aptus Health’s EngagedMedia, which supports patient engagement and adherence via an integrated mobile messaging platform; and Tomorrow Networks, which offers data-driven, location-based mobile advertising and marketing solutions driven by consumer behavior.

The acquisition will combine the core competencies and scale of Aptus Health with that of WebMD and Medscape, the flagship consumer and health care professional brands in the WebMD network.

“Aptus Health is highly complementary to WebMD’s existing professional and consumer brands, making them an excellent addition to our platforms,” said Bob Brisco, WebMD CEO. “Together, we can leverage our combined strengths to extend our reach and engagement to health care professionals, patients and consumers.”

The addition of Aptus Health’s flagship brand Univadis to the Medscape franchise will build on Medscape’s unrivaled reach as the leading global source of clinical news, health information, education and point-of-care tools for health care professionals worldwide.

“Univadis strengthens our commitment to deliver best-in-class content and tools to millions of physicians worldwide,” said Jeremy Schneider, group general manager, WebMD Global. “With Univadis, we deepen our connection to local markets, extend our reach to healthcare practitioner audiences, and increase our value to customers.”

Aptus Health is wholly owned by the pharmaceutical firm, Merck, known as MSD outside the United States and Canada. Aptus Health will continue to operate as an independent subsidiary of WebMD, as the companies build on and integrate products, platforms, and services.

The acquisition is expected to be complete in October and is subject to customary closing conditions. Terms of the deal are not being disclosed.

Research contact: @WebMD